Cargando…
The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy
The term “immune privilege” was originally coined to describe the suppression of inflammatory responses within organs protected by anatomic barriers, ie, the eyes, brain, placenta, and testes. However, cellular and metabolic processes, which orchestrate immune responses, also control inflammation wi...
Autores principales: | Routy, Jean-Pierre, Routy, Bertrand, Graziani, Gina M., Mehraj, Vikram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063567/ https://www.ncbi.nlm.nih.gov/pubmed/27773992 http://dx.doi.org/10.4137/IJTR.S38355 |
Ejemplares similares
-
Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy
por: Mehraj, Vikram, et al.
Publicado: (2014) -
The grace of aging with ART: Ex vivo dendritic cell-based immunotherapy restores HIV-specific functional CD8(+) T-cells
por: Mehraj, Vikram, et al.
Publicado: (2022) -
The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response
por: Mehraj, Vikram, et al.
Publicado: (2016) -
Immunity to PRRSV: Double-edged sword
por: Molitor, T.W., et al.
Publicado: (1997) -
HDAC inhibitors and immunotherapy; a double edged sword?
por: Kroesen, Michiel, et al.
Publicado: (2014)